What is the recommended treatment for bacterial conjunctivitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Bacterial Conjunctivitis

For bacterial conjunctivitis, a 5-7 day course of broad-spectrum topical antibiotic is recommended as it accelerates clinical and microbiological remission, reduces transmissibility, and allows earlier return to school or work. 1

First-Line Treatment Approach

  • For mild to moderate bacterial conjunctivitis, apply a broad-spectrum topical antibiotic 4 times daily for 5-7 days 1, 2
  • Fluoroquinolones (e.g., moxifloxacin, gatifloxacin) are effective against common pathogens and are recommended by the World Health Organization 1
  • For gatifloxacin specifically, instill one drop every two hours in the affected eye(s) while awake (up to 8 times) on Day 1, then one drop 2-4 times daily on Days 2-7 3
  • Most cases of bacterial conjunctivitis are self-limiting, but antibiotic treatment shortens duration and reduces transmission 2, 4

Treatment Based on Severity

  • For mild bacterial conjunctivitis, the most convenient or least expensive broad-spectrum antibiotic is appropriate as there is no clinical evidence suggesting superiority of any particular agent 2
  • For moderate to severe cases with copious purulent discharge, obtain conjunctival cultures and Gram staining before initiating treatment 1
  • Ciprofloxacin, chloramphenicol, and rifampin have shown good activity against the most prevalent pathogens (Haemophilus influenzae and Streptococcus pneumoniae) 5

Special Considerations

  • Gonococcal conjunctivitis requires systemic antibiotic therapy rather than topical treatment alone, with saline lavage to promote comfort 1
  • Chlamydial conjunctivitis requires systemic antibiotic therapy, especially in infants who may have infection at other sites 1
  • For methicillin-resistant S. aureus (MRSA) infections, vancomycin may be required 6, 2
  • Povidone-iodine 1.25% ophthalmic solution may be considered when access to antibiotics is limited 1

Follow-up Care

  • Advise patients to return for evaluation if no improvement is seen after 3-4 days of treatment 7
  • For gonococcal conjunctivitis, daily follow-up is recommended until resolution 7
  • Most uncomplicated cases of bacterial conjunctivitis resolve in 1-2 weeks 4

Prevention of Transmission

  • Instruct patients on proper hand washing to reduce transmission risk 7
  • Advise patients to avoid sharing towels, pillows, and close contact with others during the contagious period 7
  • Patients can generally return to school or work after 24 hours of treatment when symptoms begin to improve 7

Common Pitfalls and Caveats

  • Increasing bacterial resistance is a concern, particularly with MRSA infections 2
  • Never use topical antibiotics containing corticosteroids unless the conjunctivitis is proven to be non-herpetic 8
  • For children with gonococcal or chlamydial infections, consider the possibility of sexual abuse 2
  • Contact lens wearers should be advised not to wear lenses during the course of treatment 3

References

Guideline

Treatment of Bacterial Conjunctivitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Bacterial Conjunctivitis: Frequency and Duration

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Bacterial conjunctivitis: most prevalent pathogens and their antibiotic sensitivity].

Anales de pediatria (Barcelona, Spain : 2003), 2004

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Bacterial Conjunctivitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.